Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company is expected to achieve a net profit attributable to shareholders of 1.67 to 1.85 billion yuan for 2025, representing a year-on-year growth of 54.0% to 70.6% [1] - The electric two-wheeler market share has increased by 1.8 percentage points year-on-year, ranking the company fourth in the industry [2] - The company plans to enhance its service robot business, particularly focusing on lawn mowers, which are expected to show rapid growth [3] - The company is actively responding to changes in EU policies regarding lawn mowers, emphasizing its core competitiveness and innovation [4] - Profit forecasts for 2025-2027 are 1.76 billion, 2.34 billion, and 2.96 billion yuan respectively, with corresponding P/E ratios of 21.21X, 15.98X, and 12.61X [4] Financial Performance Summary - Total revenue for 2023 is reported at 10.22 billion yuan, with a year-on-year growth rate of 1.0% [6] - The net profit attributable to shareholders for 2023 is 598 million yuan, reflecting a year-on-year growth of 32.5% [6] - The gross margin is projected to increase from 25.2% in 2023 to 31.4% by 2027 [6] - The return on equity (ROE) is expected to rise from 11.0% in 2023 to 24.5% in 2027 [6]

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 九号公司(689009) 投资评级 买入 上次评级 买入 [Table_Title] 九号公司：业绩短期承压，两轮车结构转型， 割草机器人有望延续高增 [Table_ReportDate] 2026 年 01 月 30 日 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮 箱： jiangwenqiang@cindasc.com [Table_S 事件：公司ummar发布y] 2025 年度业绩预告。2025 年公司预计实现归母净利润 16.70-18.50 亿元（同比增长 54.0%-70.6%），扣非归母净利润 16.20-17.90 亿元（同比增长 52.5%-68.5%）。我们取区间中值估算，则 25Q4 预计实现 归母净利润-0.27 亿元（24Q4 为 1.14 亿元），扣非归母净利润-0.94 亿元 （24Q4 为 1.25 亿元），有所承压。我们预计汇率波动等因素或对业绩表现 造成一定影响。 骆峥 新消费行业分析师 执业编号 ...

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" [2] Core Insights - The report emphasizes the clear trend of AI in the healthcare industry, driven by policy implementation and technological breakthroughs. Key policies include the State Council's directive on AI in healthcare, aiming for widespread application of AI in diagnosis, health management, and insurance services by 2030 [10][11] - The report identifies the G-end and B-end commercial models as relatively mature, while the C-end applications, particularly the Ant Financial's "Afu" app, are still developing. The app has over 30 million monthly active users, with a significant portion from lower-tier cities [11][12] - The report highlights the importance of monitoring upcoming catalysts in 2026, including AI partnerships and new model releases from major tech companies [10][11] Summary by Sections 1. AI Empowering Healthcare Industry Development - AI is set to enhance the healthcare industry chain, with policies accelerating the integration of AI in medical services, public health, and health industry development [13] - The report outlines various AI application scenarios in healthcare, including intelligent diagnosis and drug development [13][15] 2. AI Healthcare Stock Price Movements - Stock price drivers in AI healthcare include policy changes, technological advancements, and performance realization [4] - The report notes significant technological breakthroughs and product applications in the past three years, with a focus on upcoming key events in 2026 [4][11] 3. G-end and B-end Commercialization - The G-end and B-end business models are highlighted as more established, with G-end focusing on government and healthcare needs, while B-end targets hospitals and pharmaceutical companies [11] - The C-end model is primarily based on drug sales through AI health applications, with the Ant Financial's "Afu" app leading in user engagement [11][12] 4. Key Investment Targets - The report suggests focusing on companies such as MedLinker, JD Health, Alibaba Health, iFlytek Medical Technology, Ping An Good Doctor, and Ruanda Medical for potential investment opportunities [12][11]

公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 工业富联(601138) 投资评级 买入 上次评级 买入 证券研究报告 相关研究 [Table_OtherReport] 工业富联 2025 三季报点评：Q3 净利润 突破百亿，AI 业务大幅提升 工业富联 2025 半年报点评：净利润处 于预告上限，AI CapEx 增长核心受益 工业富联 25H1 业绩预告点评：Q2 归母 净利润同比增长约 50%，AI 业务持续释 放业绩 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 [Table_Title] 工业富联 2025 业绩预增点评：Q4 业绩继续 高增，AI 驱动进入加速兑现期 [Table_ReportDate] 2026 年 1 月 29 日 | [Table_Profit] 重要财务指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业 ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 工业富联(601138) 投资评级 买入 上次评级 买入 相关研究 [Table_OtherReport] 工业富联 2025 三季报点评：Q3 净利润 突破百亿，AI 业务大幅提升 工业富联 2025 半年报点评：净利润处 于预告上限，AI CapEx 增长核心受益 工业富联 25H1 业绩预告点评：Q2 归母 净利润同比增长约 50%，AI 业务持续释 放业绩 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 [Table_Title] 工业富联 2025 业绩预增点评：Q4 业绩继续 高增，AI 驱动进入加速兑现期 [Table_ReportDate] 2026 年 1 月 29 日 | [Table_Profit] 重要财务指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业 ...

公司研究 [Table_ReportType] 公司点评报告 [安Ta踏bl体e_育Sto(c2k0A2n0d.RaHnKk)] 邮编：100031 证券研究报告 [Table_Title] 收购 PUMA29.06%股权，安踏全球化关键落子 [Table_ReportDate] 2026 年 1 月 29 日 [T事ab件le：_安Su踏mm体ar育y]于近日公告，拟以约 15.055 亿欧元（约合 122.78 亿元人民 币）收购 PUMA SE 约 29.06%股权，成为其单一最大股东。 投资评级 上次评级 收购价格点评：本次交易本次交易每股作价 35 欧元，较公告前一日收盘价 溢价 61.6%,对应 EV/2027 年预期营收的倍数约为 0.8 倍，公司认为估值合 理。全部使用内部资金支付，不新增负债，预计不会影响公司现有派息政策。 安踏此次收购 PUMA 具有战略性意义，公司与品牌互补性强。品牌价值方 面：公司看重 PUMA 作为拥有近 80 年历史的全球专业运动品牌所积淀的长 期价值与品牌资产，尤其是在足球、跑步等核心领域的专业地位，当前其股 价与估值未能充分反映这一内在价值，为长期布局提供了良好 ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 玖龙纸业(2689.HK) 上次评级 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 李晨 新消费行业分析师 执业编号：S1500525060001 邮箱：lichen1@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 玖龙纸业：盈利改善超预期，浆纸协同优势放 大 [Table_ReportDate] 2026 年 1 月 29 日 投资评级 请阅读最后一页免责声明及信息披露 http://www.cindasc.com 1 [Table_OtherReport] [Table_S 事件：公司发布 ummary] FY26H1 业绩预告（截至 25 年 12 月 31 日的六个月）。公 司预计此期间盈利为 21.5-22.5 亿元（同比+21 ...

[Table_StockAndRank] 玖龙纸业(2689.HK) 投资评级 上次评级 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 李晨 新消费行业分析师 执业编号：S1500525060001 邮箱：lichen1@cindasc.com 证券研究报告 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 公司研究 [Table_ReportType] 公司点评报告 [Table_Title] 玖龙纸业：盈利改善超预期，浆纸协同优势放 大 [Table_ReportDate] 2026 年 1 月 29 日 [Table_S 事件：公司发布 ummary] FY26H1 业绩预告（截至 25 年 12 月 31 日的六个月）。公 司预计此期间盈利为 21.5-22.5 亿元（同比+216.0%~230.7%），剔除永续 资本证券持有人应占盈利 2.01 亿元后，归母净利润为 19.5-20.5 亿元（同 比 ...

Investment Rating - The report assigns a strategic significance to the acquisition of approximately 29.06% of PUMA SE, with a target price of €35 per share, representing a 61.6% premium over the closing price prior to the announcement [2]. Core Insights - The acquisition is valued at approximately €1.505 billion (around 12.278 billion RMB), positioning the reporting company as PUMA's largest single shareholder [2]. - The company views PUMA's long-term brand value and market position, particularly in football and running, as underappreciated in its current stock price, providing a favorable long-term investment opportunity [2]. - The revenue contribution of PUMA from the Chinese market is only about 7%, indicating significant growth potential, with plans to leverage the company's successful "brand + retail" model to enhance PUMA's performance in China [2]. - The acquisition is a critical step in the company's "single focus, multi-brand, globalization" strategy, enhancing its global presence through PUMA's strong influence in Europe, North America, and Africa [2]. Financial Projections - The company has adjusted its profit forecasts, expecting net profits for the fiscal years 2025-2027 to be 13.197 billion, 14.129 billion, and 15.417 billion RMB, respectively, with corresponding P/E ratios of 14.65X, 13.68X, and 12.54X [3]. - Revenue projections for the fiscal years 2025-2028 are estimated at 70.826 billion, 78.263 billion, 85.306 billion, and 92.557 billion HKD, with year-on-year growth rates of 14%, 11%, 9%, and 9% [4]. - The company's diluted EPS is projected to be 4.72, 5.05, and 5.51 HKD for the fiscal years 2025, 2026, and 2027, respectively [4].

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 青岛银行(002948) | | | | | | 绩、资产质量全维度向好 [Table_Author] 张晓辉 银行业分析师 执业编号：S1500523080008 邮 箱：zhangxiaohui@cindasc.com 相关研究 [Table_OtherReport] 青岛银行 2025 三季报点评：扩规模、 调结构、降成本，不良指标持续优化 青岛银行 2025 一季报点评：息差逆势 提升，业绩突出、不良再降 青岛银行 2024 年报点评：规模、效益 与质量协同跃升 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 [Table_Title] 青岛银行 2025 年业绩快报点评：规模、业 [Table_ReportDate] 2026 年 01 月 29 日 [Table_S [Table_S 事件：ummar 1ummar 月 28y]y]日晚，青岛银行发布 2025 年业绩快报：2025 年，实 ...